Paediatric clinical pharmacology Flashcards
ages of a neonate
birth to 1m
age of an infant
1m-2y
age of a child
2-12y
age of an adolescent
12-18y
issues with neonates
Particularly at risk of drug toxicity
Immature drug handling by body (pharmacokinetics)
Changing drug effects (pharmacodynamics)
issues with infants
Can’t describe effects or side effects of drugs - difficult to know if they are working!
Administration issues
issues with children
Physical and intellectual development may be affected by medicines
issues with adolescents
Sexual development may be affected by medicines
Compliance issues
what is adherance
Medication adherence, or taking medications correctly, is generally defined as the extent to which patients take medication as prescribed by their doctors. Includes taking medication on time and understanding the directions.
improving adherence
Concordance
- Careful discussion of risks and benefits
- Get child on board and taking responsibility
Acceptability
-Oral administration
-Liquids for younger children - oral syringe
-Beware sugar - dental hygiene
-Consider masking taste with food
– Beware food-drug interactions/ putting child off food
-Don’t put medicines in infant feed
Injections
- Avoid painful IM injections
- Topical anaesthesia for IV lines
- Chronic use - central lines, daily subcutaneous injections…
issues with children and administering meds
Children sleep for more hours than adults
Children go to school
Parents like to give their children ‘natural’ or complementary medicines
Many medicines are not licensed for use in children
what do you need to know about PK when thinking about meds and children
PK
Toxicity
what affects PK in children
changes in metabolic capacity
developmental changes in distribution sites
changes in GI function
renal function
skin
monitoring response to meds
Symptoms
Signs
Investigations
explanations about why children sometimes have better prognosis than adults for some diseases
Pharmacodynamics Different disease biology Ph+ (bad type) paeds 3%, adults 18% Different comorbidities Children may be more able to withstand toxicity of high dose treatment
Different treatment regimens
Children
higher doses, earlier and more intensive CNS therapy
more attention to detail including dose intensification,
scheduling of dosing